Oculis Holding AG - Warrants (02/03/2028) (OCSAW)

NASDAQ

$4.94

Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company is headquartered in Zug, Switzerland.

This company is also listed under the following ticker: OCS.

Beta (5Y)

0.98

Price Chart

Adjust inflation

Log

Growth & Risk

Beta (5Y)0.98

Sharpe Ratio0.13